Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B.
Yoo JY, et al. Among authors: dai h.
Clin Cancer Res. 2016 Nov 1;22(21):5265-5276. doi: 10.1158/1078-0432.CCR-16-1003. Epub 2016 Jul 7.
Clin Cancer Res. 2016.
PMID: 27390350
Free PMC article.